One caller during Tuesday's Lightning Round segment of Mad Money quizzed Jim Cramer about Gritstone bio (GRTS) . "You want to own NovoCure (NVCR) . That's the way to go. Not this one," replied Cramer.
Let's check out some charts on both names.
First, in this daily bar chart of GRTS, below, we can see that the shares spiked rapidly higher in January and have been giving back all those gains day after day. Not a positive-looking picture.